300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Mobile
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Celebrity
Social
Cannabis
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
LGBT
Manufacturing
FinTech
Social Media
Franchise
Internet
Climate
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
LATAM
Poland
Oman
Puerto Rico
Guernsey
Cameroon
China
Colombia
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
Indonesia
United States
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Agency for Science, Technology and Research, VC Fund

Agency for Science, Technology and Research

VC Fund

Singapore, Singapore

Agency for Science, Technology and Research is a VC fund in Singapore focused on Biotechnology and Coffee. The Agency for Science, Technology and Research (A*STAR) is the lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. A*STAR oversees 18 biomedical sciences and physical sciences and engineering research entities, located in Biopolis and Fusionopolis as well as theirimmediate vicinity.A*STAR supports Singapore's key economic clusters by providing intellectual, human and industrial capital to its partners in industry. It also supports extramural research in the universities, hospitals, research centres, and with other local and international partners.

Total investments:
4
Last investment:
Lead investor:
0%

Last updated:

Industries Agency for Science, Technology and Research invests in

BiotechnologyCoffeeGoogleMedicalBig Data

Stages Agency for Science, Technology and Research invests in

Series ASeedSeries B

Countries Agency for Science, Technology and Research invests in

Singapore

Round sizes

Series A $13M–$27M

Contacts

NameEmailPhoneSocials
See all 6 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$13M–$27M

Investment Focus

Industry

  • Biotechnology 2 (50%)
  • Coffee 1 (25%)
  • Google 1 (25%)
  • Medical 1 (25%)
  • Big Data 1 (25%)
See all 14 industries →

Stage

  • Series A 2 (50%)
  • Seed 1 (25%)
  • Series B 1 (25%)

Team

NameTitleInvestmentsLinksEmail
Scientist Total investments: 0 Find email
Jia Cheong
Jia Cheong Scientist
Scientist Total investments: 0
Find email
Joshua Au
Joshua Au Head, Data Centre
Head, Data Centre Total investments: 0
Find email
Wieslaw Nowinski
Wieslaw Nowinski Director/Principal Scientist
Director/Principal Scientist Total investments: 0
Find email
Frederick Chew
Frederick Chew Chief Executive Officer
Chief Executive Officer Total investments: 0 Find email
See all 6 team members →

Investments

CompanyDescriptionRoundLinks
Prefer is a coffee manufacturing company that is bean-free. The company uses fermentation to create coffee from waste. The fermentation process converts upcycled food by-products, from beer, bread, and tofu manufacturing, into these same aroma molecules. $2M / Seed / Feb 22, 2024
Nalagenetics is a health-tech company that provides genetic testing. In 2016, the company collaborated with the Indonesian health ministry to distribute 1,000 genetic test kits in five villages in Papua and West Papua. The company's tests revealed that 20% of leprosy patients in the area carry the gene responsible for potentially fatalreactions to Dapsone, an anti-leprosy medication; this discovery assisted doctors in determining which patients could be safely treated with the antibiotic. $12.6M / Series A / Mar 25, 2022
Sentient.io AI models, microservices, and datasets are readily available through APIs on the Sentient AI & Data Cloud Platform for easy discovery. They utilize curated public and private datasets and pre-trained and industry-proven models. The company provides unique benefits to software developers looking to create AI-enabled applications orAI-driven services by embedding AI capabilities into their applications and for enterprises by making scalability a core and enabling easy extension to existing applications. Series B / Oct 27, 2021
AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers. $27M / Series A / Oct 12, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Mobile
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Celebrity
Social
Cannabis
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
LGBT
Manufacturing
FinTech
Social Media
Franchise
Internet
Climate
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
LATAM
Poland
Oman
Puerto Rico
Guernsey
Cameroon
China
Colombia
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
Indonesia
United States
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Agency for Science, Technology and Research invest in?

Agency for Science, Technology and Research invests primarily in Biotechnology, Coffee and Google startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Agency for Science, Technology and Research invest in?

Agency for Science, Technology and Research typically joins rounds of $13M–$27M at Series A. These are whole funding-round sizes, not Agency for Science, Technology and Research's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Agency for Science, Technology and Research took part in.

How do I contact Agency for Science, Technology and Research?

Public channels for Agency for Science, Technology and Research include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Agency for Science, Technology and Research?

The team at Agency for Science, Technology and Research includes Anbanandam Parthiban (Scientist), Jia Cheong (Scientist) and Joshua Au (Head, Data Centre), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Agency for Science, Technology and Research Agency for Science, Technology and Research Find emails